| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | 219,0 k € | — | — | — | — | — | — | ||||||||||||||||||
| Gross margin | -9,0 k € | +20.5% | -11,4 k € | +82.4% | -64,7 k € | -253.0% | 42,3 k € | -79.6% | 207,3 k € | +60.2% | 129,4 k € | +32.7% | 97,5 k € | -8.3% | 106,4 k € | +73.1% | 61,4 k € | -6.3% | 65,6 k € | +16.0% | 56,5 k € | -11.6% | 63,9 k € | -13.3% | 73,7 k € | +15.7% | 63,7 k € | -30.7% | 92,0 k € | +52.7% | 60,2 k € | -28.7% | 84,4 k € | +14.6% | 73,7 k € | |
| EBITDA | -15,7 k € | -7.8% | -14,5 k € | +78.6% | -67,8 k € | -272.3% | 39,4 k € | -80.6% | 203,5 k € | +59.9% | 127,3 k € | +33.2% | 95,5 k € | -8.3% | 104,2 k € | +75.3% | 59,4 k € | -6.4% | 63,5 k € | +16.4% | 54,6 k € | -12.1% | 62,1 k € | +19.8% | 51,8 k € | +62.1% | 32,0 k € | -64.4% | 89,7 k € | +63.0% | 55,0 k € | -29.9% | 78,6 k € | +14.0% | 68,9 k € | |
| Operating profit | -24,6 k € | +9.1% | -27,1 k € | +67.2% | -82,4 k € | -415.8% | 26,1 k € | -86.5% | 193,8 k € | +60.6% | 120,7 k € | +42.9% | 84,4 k € | +11.5% | 75,7 k € | +213.2% | 24,2 k € | -12.9% | 27,8 k € | +21.7% | 22,8 k € | -23.4% | 29,8 k € | +33.6% | 22,3 k € | +1118.7% | 1,8 k € | -92.7% | 25,1 k € | +16.0% | 21,7 k € | -32.6% | 32,2 k € | +65.8% | 19,4 k € | |
| Profit/loss | -26,0 k € | -0.1% | -25,9 k € | +69.1% | -83,7 k € | -1020.0% | 9,1 k € | -93.2% | 133,5 k € | +74.5% | 76,5 k € | +162.6% | 29,1 k € | -33.1% | 43,5 k € | +374.3% | 9,2 k € | -5.8% | 9,7 k € | +60.7% | 6,1 k € | -42.9% | 10,6 k € | +345.4% | 2,4 k € | +118.2% | -13,1 k € | -234.5% | 9,8 k € | +8.4% | 9,0 k € | -45.8% | 16,6 k € | +313.7% | 4,0 k € | |
| Equity | 279,1 k € | -8.5% | 305,0 k € | -7.8% | 331,0 k € | -20.2% | 414,7 k € | +2.2% | 405,6 k € | +235.6% | 120,8 k € | +172.5% | 44,3 k € | +191.6% | 15,2 k € | +153.7% | -28,3 k € | +24.5% | -37,5 k € | +20.6% | -47,2 k € | +11.4% | -53,3 k € | +16.6% | -63,9 k € | +3.6% | -66,3 k € | -11.8% | -59,3 k € | +14.1% | -69,1 k € | +11.5% | -78,1 k € | +17.5% | -94,7 k € | |
| Total assets | 333,7 k € | -11.9% | 378,8 k € | -4.6% | 397,0 k € | -26.8% | 542,2 k € | +0.6% | 538,9 k € | +55.9% | 345,7 k € | -8.0% | 375,7 k € | -0.3% | 376,9 k € | -0.8% | 379,8 k € | -5.7% | 402,8 k € | +0.3% | 401,7 k € | -11.1% | 451,9 k € | -1.8% | 460,0 k € | -5.2% | 485,2 k € | -7.4% | 524,2 k € | +38.4% | 378,7 k € | +1.0% | 375,1 k € | -9.0% | 412,1 k € | |
| Cash | 6,0 k € | 0,0 € | -100.0% | 737,2 € | -98.2% | 41,3 k € | -5.6% | 43,8 k € | — | 1,4 k € | +1584.3% | 82,5 € | — | — | 1,2 k € | -92.2% | 15,4 k € | — | — | — | 1,4 k € | -84.7% | 9,3 k € | +45.9% | 6,4 k € | |||||||||||
| Debts | 54,6 k € | -25.9% | 73,7 k € | +12.6% | 65,4 k € | -11.2% | 73,7 k € | -7.2% | 79,4 k € | -54.6% | 174,7 k € | -37.9% | 281,2 k € | -9.7% | 311,6 k € | -13.0% | 358,0 k € | -8.3% | 390,2 k € | -2.1% | 398,8 k € | -12.4% | 455,0 k € | -4.0% | 473,8 k € | -9.1% | 521,5 k € | -10.6% | 583,5 k € | +30.6% | 446,7 k € | -1.4% | 453,2 k € | -10.6% | 506,8 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0,1 | 0,1 | — | — | ||||||||||||||||||
Source: Belgian Official Gazette
Private company with limited liability · Merelbeke-Melle · incorporated on 08/06/1995
Private company with limited liability loss-making in the latest fiscal year.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MEDISCH KABINET DR. HOORENS G. is a Private company with limited liability incorporated in 1995. Its main activity is: Other human health activities. Its registered office is in Merelbeke-Melle.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.